Download the free ESC Pocket Guidelines App and its interactive tools onto your mobile device.

HeartScore is the ESC interactive tool to calculate the 10-year risk of fatal and non-fatal cardiovascular disease events, updated with SCORE 2, SCORE 2-OP and recommendations from the 2021 ESC Guidelines on CVD Prevention in Clinical Practice, for healthcare professionals and their patients.

The European Society of Cardiology (ESC) is a leading medical society in the discovery and dissemination of best practices in cardiovascular medicine. In collaboration with the SCORE2 …

HeartScore is now updated with the SCORE2 and SCORE2-OP algorithms with recommendations for physicians and patients, from the 2021 ESC Guidelines on CVD Prevention in Clinical Practice.

SCORE2-Older Persons (SCORE2-OP) predicts 10-year CVD risk in older patients.

SCORE - European High Risk Chart 10 year risk of fatal CVD in high risk regions of Europe by gender, age, systolic blood pressure, total cholesterol and smoking status

Assess individual cardiovascular risk for different patient populations. Developed by the European Association of Preventive Cardiology, the ESC CVD Risk Calculation App provides guidance on which is the most appropriate calculator for your patient, as well as up to 10-years or life-long risk.

2022年8月10日 · The new ESC Guideline on CVD prevention offers two new risk calculators: the SCORE2 (40 to 69 years) and the SCORE2-OP (≥ 70 years). The calculators can be rapidly and easily used online by "apparently healthy" persons themselves or by their health care provider.

Das Programm errechnet das Risiko für einen tödlichen Herzinfarkt innerhalb der nächsten 10 Jahre anhand der 2003 im European Journal of Cardiovascular Prevention and Rehabilitation erschienenen Punktescores. Im März 2005 wurde eine Version mit den Daten für Deutschland veröffentlicht. Das Risiko in Deutschland liegt zwischen der low-risk und high-risk Gruppe in Europa. Dieser Rechner ...

2023年8月27日 · 在2023年欧洲心脏病学会（ESC）的现场会议上，Sofian Johar教授在LBS2专场上公布了一项最新的科学研究。 这项研究针对亚洲人群，旨在探索改良的SCORE2-ASIA模型在预测非糖尿病或心